BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹100 Cr | ₹74 Cr | ₹81 Cr | ₹-241 Cr | ₹-275 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹100 Cr |
Mar2024 | ₹74 Cr |
Mar2023 | ₹81 Cr |
Mar2022 | ₹-241 Cr |
Mar2021 | ₹-275 Cr |
How is Deferred Tax Assets / Liabilities of BIOCON Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹100 Cr | 34.77 | |
Mar2024 | ₹74 Cr | -8.17 | |
Mar2023 | ₹81 Cr | Positive | |
Mar2022 | ₹-241 Cr | Negative | |
Mar2021 | ₹-275 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹48,693.5 Cr | 6.5% | -8.2% | 9.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 1.2% | -4.2% | -5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3% | -9.1% | 31.5% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 4.1% | 5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.1% | 4.3% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.7% | 0.1% | -7.4% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | 6.5% |
-8.2% |
9.7% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses